HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation.

AbstractPURPOSE:
To evaluate the effect of hepatitis D virus (HDV) on hepatitis B virus-hepatocellular carcinoma (HBV-HCC) co-recurrence in patients undergoing living donor liver transplantation (LDLT) for HBV alone or HBV-HDV coinfection.
METHODS:
Between 2002 and 2019, 254 HBV-HCC patients underwent LDLT. The patients were divided into two groups after the application of the exclusion criteria: HBV-HCC (Group B; n = 163) and HBV-HDV-HCC (Group D; n = 31). First, the B and D groups were compared in terms of demographic and clinical parameters. Second, patients with (n = 16) and without (n = 178) post-transplant HBV-HCC co-recurrences were grouped and compared in terms of the same parameters.
RESULTS:
Although the risk of HBV-HCC co-recurrence in group D was 4.99-fold higher than in group B, the risk of HBV recurrence alone in group D was 12.5-fold lower than in group B. The AFP (OR = 4.4), Milan criteria (beyond; OR = 18.8), and HDV (OR = 8.1) were identified as the independent risk factors affecting post-transplant HBV-HCC co-recurrence. The Milan criteria (OR = 2.1) and HBV-HCC co-recurrence (OR = 10.9) were identified as the risk factors affecting post-transplant mortality. HBV-HCC co-recurrence developed in 26.5% of patients in Group B and 100% in Group D (OR = 40; p = 0.001). HCC recurrence alone developed in 10% of patients without HBV recurrence in group B and 0% of patients without HBV recurrence in group D (OR = 5.7).
CONCLUSION:
This study showed that the risk of HBV recurrence alone was reduced by 12.5-fold in the presence of HDV; however, the HCC recurrence occurred in all patients with HDV when HBV recurrence developed.
AuthorsAdil Baskiran, Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Serdar Karakas, Volkan Ince, Cihan Yurdaydin, Sezai Yilmaz
JournalHepatology international (Hepatol Int) Vol. 14 Issue 5 Pg. 869-880 (Sep 2020) ISSN: 1936-0541 [Electronic] United States
PMID32895876 (Publication Type: Journal Article)
Topics
  • Adult
  • Carcinoma, Hepatocellular (epidemiology, pathology, surgery, virology)
  • Coinfection (epidemiology, virology)
  • Female
  • Hepatitis B virus (isolation & purification, pathogenicity)
  • Hepatitis B, Chronic (complications, diagnosis, epidemiology, physiopathology)
  • Hepatitis D (complications, diagnosis)
  • Hepatitis Delta Virus (isolation & purification)
  • Humans
  • Liver Neoplasms (epidemiology, pathology, surgery, virology)
  • Liver Transplantation (adverse effects, methods)
  • Male
  • Postoperative Complications (diagnosis, physiopathology, virology)
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Turkey (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: